Penumbra, Inc. (BMV:PEN)

Market Cap	228.17B +7.3%
Revenue (ttm)	24.46B +14.6%
Net Income	3.01B +374.8%
EPS	75.90 +367.3%
Shares Out	n/a
PE Ratio	75.84
Forward PE	71.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	446
Open	4,775.70
Previous Close	4,911.82
Day's Range	4,775.70 - 4,775.70
52-Week Range	3,904.75 - 4,911.82
Beta	n/a
RSI	55.88
Earnings Date	Feb 23, 2026

About Penumbra

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDW...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2004
• Employees: 4,500
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PEN

Financial Performance

In 2024, Penumbra's revenue was $1.19 billion, an increase of 12.86% compared to the previous year's $1.06 billion. Earnings were $14.01 million, a decrease of -84.59%.

Financial numbers in USD